Anaergia Valuation
| ANRG Stock | 0.95 0.03 3.06% |
Today, the firm appears to be overvalued. Anaergia shows a prevailing Real Value of USD0.9 per share. The current price of the firm is USD0.95. Our model approximates the value of Anaergia from analyzing the firm fundamentals such as return on equity of -0.84, and Profit Margin of (0.70) % as well as examining its technical indicators and probability of bankruptcy. Key fundamental drivers impacting Anaergia's valuation include:
Price Book 1.3251 | Enterprise Value 194.7 M | Enterprise Value Ebitda (97.13) | Price Sales 1.4309 | Forward PE 8.8183 |
Overvalued
Today
Please note that Anaergia's price fluctuation is abnormally volatile at this time. Calculation of the real value of Anaergia is based on 3 months time horizon. Increasing Anaergia's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Since Anaergia is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Anaergia Stock. However, Anaergia's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 0.95 | Real 0.9 | Hype 1.1 |
The intrinsic value of Anaergia's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Anaergia's stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of Anaergia helps investors to forecast how Anaergia stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Anaergia more accurately as focusing exclusively on Anaergia's fundamentals will not take into account other important factors: Traditionally, analysts and sophisticated investors use multiple methods for valuing a cash-flow-generating entity or its stock. For example, some money managers use Anaergia's intrinsic value based on its ongoing forecasts of Anaergia's financial statements. In contrast, other private, professional wealth advisors use a multiplier approach by looking to relative value analysis against Anaergia's closest peers.
Anaergia Cash |
|
Anaergia Valuation Trend
Knowing Anaergia's actual value is paramount for traders when making sound investment determinations. Using both Anaergia's enterprise value as well as its market capitalization is the best way to estimate the value of the company and is usually enough for investors to make market timing decisions.
Anaergia Total Value Analysis
Anaergia is presently estimated to have takeover price of 194.74 M with market capitalization of 164.18 M, debt of 70.89 M, and cash on hands of 55.38 M. Please note that takeover price may be misleading and is a subject to mistakes in financial statements. We encourage investors to thoroughly investigate all of the Anaergia fundamentals before making investing decisions based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
194.74 M | 164.18 M | 70.89 M | 55.38 M |
Anaergia Investor Information
About 55.0% of the company shares are held by company insiders. The company has price-to-book (P/B) ratio of 1.33. Some equities with similar Price to Book (P/B) outperform the market in the long run. Anaergia recorded a loss per share of 0.95. The entity had not issued any dividends in recent years. Based on the key measurements obtained from Anaergia's financial statements, Anaergia may be sliding down financialy. It has an above-average probability of going through some form of financial hardship next quarter.Anaergia Asset Utilization
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. Anaergia has an asset utilization ratio of 52.83 percent. This suggests that the Company is making USD0.53 for each dollar of assets. An increasing asset utilization means that Anaergia is more efficient with each dollar of assets it utilizes for everyday operations.Anaergia Ownership Allocation
Anaergia holds a total of 169.26 Million outstanding shares. Anaergia retains significant amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares. Since such a large part of the company is owned by insiders, it is advisable to analyze if each of these insiders have been buying or selling the stock in recent months. Please note that no matter how many assets the company secures, if the real value of the firm is less than the current market value, you may not be able to make money on it.Anaergia Profitability Analysis
The company reported the revenue of 147.22 M. Net Loss for the year was (182.6 M) with profit before overhead, payroll, taxes, and interest of 28.6 M.About Anaergia Valuation
We use absolute and relative valuation methodologies to arrive at the intrinsic value of Anaergia. In general, an absolute valuation paradigm, as applied to this company, attempts to find the value of Anaergia based exclusively on its fundamental and basic technical indicators. By analyzing Anaergia's financials, quarterly and monthly indicators, and their related drivers, we attempt to find the most accurate representation of Anaergia's intrinsic value. As compared to an absolute model, our relative valuation model uses a comparative analysis of Anaergia. We calculate exposure to Anaergia's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Anaergia's related companies.| Last Reported | Projected for Next Year | ||
| Gross Profit | 13.9 M | 25.8 M | |
| Pretax Profit Margin | (1.37) | (1.30) | |
| Operating Profit Margin | (0.58) | (0.55) | |
| Net Loss | (1.24) | (1.18) | |
| Gross Profit Margin | 0.10 | 0.09 |
Other Information on Investing in Anaergia Stock
Anaergia financial ratios help investors to determine whether Anaergia Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Anaergia with respect to the benefits of owning Anaergia security.